An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation
000426
Phase 1 other active
Quick answer
An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation for Infertility in women undergoing assisted reproductive technologies (ART) is a Phase 1 program (other) at Ferring Pharmaceuticals A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ferring Pharmaceuticals A/S
- Indication
- Infertility in women undergoing assisted reproductive technologies (ART)
- Phase
- Phase 1
- Modality
- other
- Status
- active